TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion

Cell and Tissue Research

Volumn 346, Issue 1, 2011, Pages 79-88

  Hisanaga, Takuro ^a   Terai, Shuji ^a   Iwamoto, Takuya ^a   Takami, Taro ^a   Yamamoto, Naoki ^a   Murata, Tomoaki ^b   Matsuyama, Toshifumi ^c   Nishina, Hiroshi ^d   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone marrow cell; CCl 4; Hepatic stellate cell; Liver cirrhosis; Tumor necrosis factor

Indexed keywords

CARBON TETRACHLORIDE; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CONTROLLED STUDY; FEMALE; HEPATITIS; LIVER FIBROSIS; LIVER TOXICITY; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STELLATE CELL; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; LIVER CIRRHOSIS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

MUS;

EID: 80755153030     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1236-0     Document Type: Article

References (34)

1. I Alwayn J Verbesey S Kim, et al. 2008 A critical role for matrix metalloproteinases in liver regeneration J Surg Res 145 192 198 18222481 10.1016/j.jss.2007.04.002 1:CAS:528:DC%2BD1cXjtVeqtrk%3D
2. I Bahcecioglu S Koca O Poyrazoglu, et al. 2008 Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis Inflammation 31 215 221 18427963 10.1007/s10753-008-9067-1 1:CAS:528:DC%2BD1cXos1Wmt7o%3D
3. Dalakas E, Newsome P, Boyle S, et al. (2009) Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev
4. V Drill 1952 Hepatotoxic agents; mechanism of action and dietary interrelationship Pharmacol Rev 4 1 42 14929693 1:CAS:528:DyaG38Xisleltw%3D%3D
5. J Duffield S Forbes C Constandinou, et al. 2005 Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair J Clin Invest 115 56 65 15630444 1:CAS:528:DC%2BD2MXis1eksw%3D%3D (Pubitemid 40385505)
6. JA Fallowfield M Mizuno TJ Kendall, et al. 2007 Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis J Immunol 178 5288 5295 17404313 1:CAS:528:DC%2BD2sXjslWjtLg%3D (Pubitemid 46595314)
7. C Gardner J Laskin D Dambach, et al. 2003 Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators Toxicol Appl Pharmacol 192 119 130 14550746 10.1016/S0041-008X(03)00273-4 1:CAS:528:DC%2BD3sXnvVyru7w%3D (Pubitemid 37194516)
8. M Haak-Frendscho S Marsters J Mordenti, et al. 1994 Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody J Immunol 152 1347 1353 8301136 1:CAS:528:DyaK2cXisVait7k%3D
9. T Haruyama I Ajioka T Akaike, et al. 2000 Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling Biochem Biophys Res Commun 272 681 686 10860814 10.1006/bbrc.2000.2837 1:CAS:528: DC%2BD3cXktVKksbg%3D (Pubitemid 30420698)
10. R Higashiyama Y Inagaki Y Hong, et al. 2007 Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice Hepatology 45 213 222 17187438 10.1002/hep.21477 1:CAS:528: DC%2BD2sXht1artrc%3D (Pubitemid 46144381)
11. T Horn T O'Brien L Schook M Rutherford 2000 Acute hepatotoxicant exposure induces TNFR-mediated hepatic injury and cytokine/apoptotic gene expression Toxicol Sci 54 262 273 10746953 10.1093/toxsci/54.1.262 1:CAS:528: DC%2BD3cXhvVChtrw%3D (Pubitemid 30152477)
12. T Inui H Nakashima Y Habu, et al. 2005 Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice J Hepatol 43 670 678 15922476 10.1016/j.jhep.2005.02.027 1:CAS:528:DC%2BD2MXpvFamtL8%3D (Pubitemid 41253235)
13. S Khurana A Mukhopadhyay 2007 Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue Stem Cells 25 1439 1447 17379762 10.1634/stemcells.2006-0656 1:CAS:528:DC%2BD2sXntlWrtrY%3D (Pubitemid 47106011)
14. K Kitamura Y Nakamoto M Akiyama, et al. 2002 Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis Lab Invest 82 571 583 12003998 10.1038/labinvest.3780452 1:CAS:528:DC%2BD38Xks1Wksrs%3D (Pubitemid 34522370)
15. C Liu Q Tao M Sun, et al. 2010 Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats Lab Invest 90 1805 1816 20921949 10.1038/labinvest.2010.123 1:CAS:528: DC%2BC3cXhsVyhs73I
16. R Moreira 2007 Hepatic stellate cells and liver fibrosis Arch Pathol Lab Med 131 1728 1734 17979495 1:CAS:528:DC%2BD2sXhsVSisbrI (Pubitemid 350077474)
17. K Omori S Terai T Ishikawa, et al. 2004 Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression FEBS Lett 578 10 20 15581608 10.1016/j.febslet.2004.09.090 1:CAS:528:DC%2BD2cXhtVClt7jE (Pubitemid 39576092)
18. CJ Parsons M Takashima RA Rippe 2007 Molecular mechanisms of hepatic fibrogenesis J Gastroenterol Hepatol 22 Suppl 1 S79 S84 17567474 10.1111/j.1440-1746.2006.04659.x 1:CAS:528:DC%2BD2sXptFersrs%3D (Pubitemid 46848998)
19. K Pfeffer T Matsuyama TM Kunding, et al. 1993 Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 73 457 467 8387893 10.1016/0092-8674(93) 90134-C 1:CAS:528:DyaK3sXkt1GksrY%3D (Pubitemid 23143346)
20. S Robinson K Scott F Balkwill 2002 Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha Eur J Immunol 32 404 412 11813159 10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X 1:CAS:528:DC%2BD38XhvVeht7w%3D (Pubitemid 34173332)
21. I Sakaida 2008 Autologous bone marrow cell infusion therapy for liver cirrhosis J Gastroenterol Hepatol 23 1349 1353 18422964 10.1111/j.1440-1746. 2008.05381.x
22. I Sakaida S Terai N Yamamoto, et al. 2004 Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice Hepatology 40 1304 1311 15565662 10.1002/hep.20452 (Pubitemid 39657004)
23. H Shibata Y Yoshioka A Ohkawa, et al. 2008 The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models Cytokine 44 229 233 18815054 10.1016/j.cyto.2008.07.003 1:CAS:528: DC%2BD1cXhtlyhtr3L
24. H Shibata Y Yoshioka A Ohkawa, et al. 2008 Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist J Biol Chem 283 998 1007 18003610 10.1074/jbc.M707933200 1:CAS:528:DC%2BD1cXhsFegsw%3D%3D
25. P Simeonova R Gallucci T Hulderman, et al. 2001 The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride Toxicol Appl Pharmacol 177 112 120 11740910 10.1006/taap.2001.9304 1:CAS:528:DC%2BD3MXovFGhu7w%3D (Pubitemid 34033045)
26. K Sudo Y Yamada H Moriwaki K Saito, et al. 2005 Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice Cytokine 29 236 244 15760680 10.1016/j.cyto.2004.11.001 1:CAS:528:DC%2BD2MXitFequ7c%3D (Pubitemid 40326610)
27. F Tacke T Luedde C Trautwein 2009 Inflammatory pathways in liver homeostasis and liver injury Clin Rev Allergy Immunol 36 4 12 18600481 10.1007/s12016-008-8091-0 1:CAS:528:DC%2BD1MXpt1ChtQ%3D%3D
28. S Terai I Sakaida 2008 Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients Hepatol Res 38 S72 S75 19125956 10.1111/j.1872-034X.2008.00430.x
29. S Terai N Yamamoto K Omori, et al. 2002 A new cell therapy using bone marrow cells to repair damaged liver J Gastroenterol 37 Suppl 14 162 163 12572886 1:CAS:528:DC%2BD38XpsleqtbY%3D (Pubitemid 35385951)
30. S Terai I Sakaida N Yamamoto, et al. 2003 An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes J Biochem 134 551 558 14607982 10.1093/jb/mvg173 1:CAS:528:DC%2BD3sXhtVWgtbrK (Pubitemid 37442878)
31. S Terai I Sakaida H Nishina, et al. 2005 Lesson from the GFP/CCl4 model-translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis J Hepatobiliary Pancreat Surg 12 203 207 15995808 10.1007/s00534-005-0977-0 (Pubitemid 40975520)
32. G Vaday H Schor M Rahat, et al. 2001 Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes J Leukoc Biol 69 613 621 11310848 1:CAS:528: DC%2BD3MXivVagu7g%3D (Pubitemid 32294847)
33. Y Yamada N Fausto 1998 Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor Am J Pathol 152 1577 1589 9626061 1:CAS:528:DyaK1cXktVSku7Y%3D (Pubitemid 28275015)
34. Y Yamada I Kirillova J Peschon, et al. 1997 Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor Proc Natl Acad Sci USA 94 1441 1446 9037072 10.1073/pnas.94.4.1441 1:CAS:528:DyaK2sXhtl2is7s%3D (Pubitemid 27087870)